ATS 2024 Final Program

Click on the session title to view the speakers

92

SUNDAY • MAYs 19

NIEHS MID-DAY SESSION

NHLBI MID-DAY SESSION

MD4 PRECISION ENVIRONMENTAL HEALTH AND ALL OF US: AN OPPORTUNITY FOR PULMONARY MEDICINE 12:00 p.m. - 1:00 p.m. San Diego Convention Center Room 32A-B (Upper Level) Target Audience Clinicians, clinician scientists, basic research scientists, fellows and residents Objectives At the conclusion of this session, the participant will be able to: • gain knowledge on the intersection between genetic predisposition and exposure to environmental agents/chemicals that may initiate and/or exacerbate preexisting pulmonary morbidities. • educating and promoting participation of diverse populations into All of Us prospective cohort and access to data for evaluating genetic and exposure relationships in pulmonary diseases. • tools for integrating large data sets from cohorts, clincal, genetic, and health data as well as geospatial exposure data for predicting exposure-response relationships in diseae etiology. The NIH All of Us Research Program aims to enroll more than one million participants to build a large-scale health database in the USA. The overarching goal of All of Us is to understand risk factors, ranging from environmental factors, lifestyle choices, and family health history, that may associate with disease at the individual level. The NIEHS is collaborating with All of Us to integrate precise exposure data that will help unravel the complexities of environmental factors in the etiology and predisposition to diverse morbidities. This session will focus on opportunities for access to characterize environmental influences in pulmonary morbidity. 12:00 Introduction 12:05 Leveraging the All of Us Research Program to Advance Pulmonary Disease Research 12:22 Disentangling Racial Disparities in Asthma Readmission using a Causal Inference Approach in the All of Us Research program 12:39 Incorporating Environmental Exposure Data Into Established Cohorts 12:56 Q&A

MD5 PRECISIONS - APPLYING PRECISION MEDICINE APPROACHES TO PULMONARY FIBROSIS 12:00 p.m. - 1:00 p.m. San Diego Convention Center Room 24A-C (Upper Level) Target Audience Those with research interests or clinical responsibilities focused on interstitial lung disease Objectives At the conclusion of this session, the participant will be able to: • discuss the central goals of precision medicine and what is being done in the field of pulmonary fibrosis to meet these goals. • highlight the PRECISIONS-IPF trial rationale, status, and key outcomes to be tested. • learn new multi-omics findings generated by the PRECISIONS study and derived from the PFF foundation biobank. PRECISIONS is a research program with an overall objective of bringing a precision medicine approach to pulmonary fibrosis. This session at ATS will provide the following information: (1) an overview of the PRECISIONS research program and its mission, (2) resources and data generated that are available for other investigators with particular encouragement for early-stage investigators, and (3) data generated by PRECISIONS ancillary studies related to different omics platforms and disease monitoring approaches in idiopathic pulmonary fibrosis and other interstitial lung disease types. 12:00 Introduction and Rationale for the PRECISIONS-IPF Study 12:15 Multi-Omics in PRECISIONS-IPF

12:30 Home Spirometry in PRECISIONS-IPF 12:45 Ancillary Studies in PRECISIONS-IPF and Concluding Remarks

ATS 2024 Conference Program • San Diego, CA